Yun Feng

ORCID: 0000-0002-8998-1145 · 11 papers in corpus
lab-animal 2026
Molecular reproduction and development ·doi:10.1002/mrd.70143

Diminished ovarian reserve (DOR) is associated with poor reproductive outcomes; however, the underlying molecular mechanisms-particularly those involving the regulation of granulosa cell (GC) function by exosomal microRNAs (miRNAs) derived …

other 2021
PeerJ ·doi:10.7717/peerj.11045

BACKGROUND: Endometriosis is a common gynecological disease among women in their reproductive years. Although much effort has been made, the pathogenesis of this disease and the detailed differences between eutopic endometrial cells and ect…

observational 2021
BMC women's health ·doi:10.1186/s12905-021-01216-5

BACKGROUND: The present study aims to provide a comparative analysis of the etiologies of female infertility between Dehong, on the Yunnan Frontier, and Kunming. METHODS: A retrospective study, which included 941 infertile females in Kunmi…

other 2021
BMJ open ·doi:10.1136/bmjopen-2020-044347

INTRODUCTION: Leiomyoma recurrence is a major concern for long-term myomectomy management, especially for multiple leiomyomas. Gonadotropin-releasing hormone agonist (GnRHa) is one of the most effective medications to reduce the volume of f…

observational 2020
BMC pregnancy and childbirth ·doi:10.1186/s12884-020-03322-y

BACKGROUND: This cross-sectional study aimed to evaluate the levels of tumor necrosis factor-alpha (TNF-ɑ), interleukin-8 (IL-8), interleukin-6 (IL-6), and transforming growth factor-beta 1 (TGF-β1) in patients with primary and secondary tu…

lab-animal 2018
Drug design, development and therapy ·doi:10.2147/dddt.s162541

PURPOSE: Adenomyosis has a negative impact on female fertility. GnRH agonist treatment can improve pregnancy outcomes in women with adenomyosis. However, the impact of GnRH agonist upon endometrium receptivity of patients with adenomyosis r…

lab-animal 2017
Drug design, development and therapy ·doi:10.2147/dddt.s127889

PURPOSE: Adenomyosis is a common, benign gynecological condition of the female reproductive tract characterized by heavy menstrual bleeding and dysmenorrhea. Gonadotropin-releasing hormone (GnRH) agonists are one of the medications used in …

observational 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115597761

In this study, we aimed to clarify the inflammatory cytokine profile of endometrium in patients with adenomyosis during the implantation window after ovarian stimulation. Eighteen patients with adenomyosis and 24 control patients undergoing…

observational 2013
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513590.2013.824960

Some studies have shown that long-term gonadotropin-releasing hormone (GnRH) agonist administration before in vitro fertilization/intracytoplasmic sperm in infertile women with endometriosis or adenomyosis significantly increases the chance…

observational 2011
Asian journal of andrology ·doi:10.1038/aja.2011.77

The aim of this study was to investigate whether the sperm chromatin structure assay (SCSA) results after swim-up are related to fertilization rates, embryo quality and pregnancy rates following in vitro fertilization (IVF). A total of 223 …

review 2011

GnRH agonist(GnRHa) is a kind of medicine most widely used to treat endometriosis.Endometriosis reduces the fecundity of women from many aspects.However,GnRHa can improve the abdominal and follicular environment,receptivity of uterine to em…